Prospective Double Blind Randomized Trial of Intramuscular Ziprasidone Compared With Standard Antipsychotic Therapy For The Treatment Of The Acutely Agitated Patient In The Emergency Department.

Trial Profile

Prospective Double Blind Randomized Trial of Intramuscular Ziprasidone Compared With Standard Antipsychotic Therapy For The Treatment Of The Acutely Agitated Patient In The Emergency Department.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 15 Sep 2017

At a glance

  • Drugs Ziprasidone (Primary) ; Haloperidol; Lorazepam
  • Indications Agitation
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Sep 2017 Planned End Date changed from 1 Jan 2010 to 1 July 2011.
    • 12 Sep 2017 Planned primary completion date changed from 1 Jan 2010 to 1 July 2011.
    • 12 Sep 2017 Status changed from active, no longer recruiting to withdrawn prior to enrolment.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top